Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revgenetics is a life sciences company specializing in the development and distribution of advanced nutritional supplements focused on longevity and anti-aging. The company is widely recognized for its high-potency resveratrol formulations, including micronized and emulsified versions designed for superior bioavailability. Beyond resveratrol, Revgenetics offers a range of products targeting cellular health, such as Nicotinamide Mononucleotide (NMN), telomerase activators like TA-65, and senolytics. Their business model centers on translating longevity research into accessible consumer products, often providing high-purity ingredients that were previously only available in research settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revgenetics.